{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:20:14Z","timestamp":1789885214544,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vaccine.2016.11.026","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T15:47:05Z","timestamp":1479397625000},"page":"6464-6471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses"],"prefix":"10.1016","volume":"34","author":[{"given":"Dan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.11.026_b0005","unstructured":"WHO: H7N9 virus \u201cone of the most lethal so far\u201d. CNN. Available at: http:\/\/edition.cnn.com\/2013\/04\/24\/world\/asia\/china-birdflu\/index.html [accessed 25 April 2013]."},{"key":"10.1016\/j.vaccine.2016.11.026_b0010","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1304617","article-title":"Epidemiology of human infections with avian influenza A(H7N9) virus in China","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.11.026_b0015","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.11.026_b0020","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1038\/emi.2013.48","article-title":"Human H7N9 avian influenza virus infection: a review and pandemic risk assessment","volume":"2","author":"Lai","year":"2013","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2016.11.026_b0025","doi-asserted-by":"crossref","first-page":"e1000709","DOI":"10.1371\/journal.ppat.1000709","article-title":"Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host","volume":"5","author":"Gao","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.11.026_b0030","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.vaccine.2009.01.116","article-title":"A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine","volume":"27","author":"Cox","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.026_b0035","doi-asserted-by":"crossref","first-page":"e49704","DOI":"10.1371\/journal.pone.0049704","article-title":"A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine","volume":"7","author":"Couch","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.11.026_b0040","first-page":"2467","article-title":"Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections","volume":"111","author":"Chen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.11.026_b0045","doi-asserted-by":"crossref","first-page":"e1000796","DOI":"10.1371\/journal.ppat.1000796","article-title":"Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.11.026_b0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1743-422X-8-42","article-title":"Characterization of an H10N8 influenza virus isolated from Dongting lake wetland","volume":"8","author":"Zhang","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2016.11.026_b0055","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/1743-422X-9-286","article-title":"Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein","volume":"9","author":"Luo","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2016.11.026_b0060","article-title":"Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope","author":"Chen","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.vaccine.2016.11.026_b0065","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(06)69294-5","article-title":"Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial","volume":"368","author":"Lin","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.11.026_b0070","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1073\/pnas.96.4.1651","article-title":"Origin and evolution of the 1918 \u201cSpanish\u201d influenza virus hemagglutinin gene","volume":"96","author":"Ann","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.11.026_b0075","doi-asserted-by":"crossref","first-page":"414637","DOI":"10.1155\/2015\/414637","article-title":"Prospects of HA-based universal influenza vaccine","volume":"2015","author":"Hashem","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2016.11.026_b0080","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1073\/pnas.1414070111","article-title":"Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans","volume":"111","author":"Ellebedy","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.11.026_b0085","doi-asserted-by":"crossref","first-page":"13701","DOI":"10.1073\/pnas.1007465107","article-title":"Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge","volume":"107","author":"Bommakanti","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.11.026_b0090","doi-asserted-by":"crossref","first-page":"18979","DOI":"10.1073\/pnas.1013387107","article-title":"Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.11.026_b0095","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1128\/CVI.00468-09","article-title":"Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes","volume":"17","author":"Sominskaya","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.11.026_b0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000050084","article-title":"Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes","volume":"45","author":"Pumpens","year":"2002","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2016.11.026_b0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.virol.2005.04.004","article-title":"Universal influenza A vaccine: optimization of M2-based constructs","volume":"337","author":"Filette","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.11.026_b0110","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.11.026_b0115","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.vaccine.2005.08.061","article-title":"The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection","volume":"24","author":"Filette","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.026_b0120","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/IAI.63.9.3279-3286.1995","article-title":"A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization","volume":"63","author":"Hopkins","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.11.026_b0125","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-3083.1997.d01-159.x","article-title":"Nasal lymphoid tissue (NALT) as a mucosal immune inductive site","volume":"46","author":"Wu","year":"1997","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2016.11.026_b0130","doi-asserted-by":"crossref","first-page":"981","DOI":"10.4049\/jimmunol.149.3.981","article-title":"Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit","volume":"149","author":"Tamura","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.11.026_b0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0264-410X(90)90053-O","article-title":"Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination","volume":"8","author":"Hirabayashi","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.026_b0140","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1073\/pnas.89.15.6901","article-title":"Intracellular neutralization of virus by immunoglobulin A antibodies","volume":"89","author":"Mazanec","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.11.026_b0145","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/JVI.69.2.1339-1343.1995","article-title":"Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies","volume":"69","author":"Mazanec","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.11.026_b0150","doi-asserted-by":"crossref","first-page":"10972","DOI":"10.1128\/JVI.76.21.10972-10979.2002","article-title":"Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model","volume":"76","author":"Yan","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.11.026_b0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0065-2776(08)60536-2","article-title":"Mechanism and regulation of immunoglobulin isotype switching","volume":"54","author":"Coffman","year":"1993","journal-title":"Adv Immunol"},{"key":"10.1016\/j.vaccine.2016.11.026_b0160","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2016.11.026_b0165","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.chom.2015.02.012","article-title":"Influenza vaccines: challenges and solutions","volume":"17","author":"Houser","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2016.11.026_b0170","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope: implications for universal prevention and therapy","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.11.026_b0175","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2016.11.026_b0180","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/JVI.03183-13","article-title":"H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge","volume":"88","author":"Krammer","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.11.026_b0185","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm1210-1389","article-title":"Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine","volume":"16","author":"Nabel","year":"2010","journal-title":"Nat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T23:36:14Z","timestamp":1692574574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16310738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":37,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0264410X16310738"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}